Immuglo 50ml (Human Normal Immunoglobulin for IV USE IP 5% Vials) 2.5gm/50ml

Immuglo 50ml is used to treat conditions related to immune system deficiencies and autoimmune disorders. It provides essential antibodies to patients who lack sufficient immune protection.

• Primary immunodeficiency diseases: Supports patients with congenital immune deficiencies by providing necessary antibodies.
• Secondary immunodeficiency: Helps patients undergoing chemotherapy or other treatments that suppress the immune system.
• Idiopathic thrombocytopenic purpura: Increases platelet counts in patients with autoimmune-related low platelet levels.
• Kawasaki disease: Reduces inflammation in blood vessels and prevents complications in children.

• Immuglo 50ml works by providing passive immunity through the administration of pooled human immunoglobulin G (IgG) antibodies. These antibodies neutralize pathogens and modulate immune responses, helping to restore normal immune function in patients with deficiencies or autoimmune disorders. The mechanism involves binding to antigens, marking them for destruction, and regulating the immune system to prevent excessive inflammation.

Immuglo 50ml may cause various side effects, ranging from mild to severe. Common Side Effects:

• Headache: Mild to moderate headache may occur during or after infusion.
• Fatigue: Feeling tired or weak is a common reaction.
• Nausea: Some patients may experience mild nausea.
• Chills: Mild chills or fever may occur during infusion.
• Muscle aches: General muscle discomfort may be experienced.
• Dizziness: Lightheadedness or dizziness can occur.

Serious or Rare Side Effects

• Anaphylaxis: Severe allergic reactions, though rare, can be life-threatening.
• Aseptic meningitis: Inflammation of the brain's linings, characterized by severe headache, fever, and neck stiffness.
• Thrombosis: Blood clots may form, leading to serious complications.
• Kidney problems: Rarely, kidney function may be affected, especially in patients with pre-existing kidney issues.
• Pulmonary oedema: Fluid accumulation in the lungs, leading to breathing difficulties.

Immuglo 50ml should be used with caution in certain patient populations and conditions. Precautions include:

• Allergy: Inform your doctor if you have a history of allergic reactions to immunoglobulin products.
• Blood clotting disorders: Use with caution in patients with a history of blood clots.
• Kidney problems: Monitor kidney function regularly, especially in patients with pre-existing kidney issues.
• Pregnancy: Safety in pregnancy has not been established; consult your doctor before use.
• Breastfeeding: Safety during breastfeeding has not been established; consult your doctor before use.
• Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Immuglo 50ml may interact with other medications, requiring careful monitoring. Major Interactions (Avoid):

• Live vaccines: Avoid concurrent use with live vaccines, as Immuglo 50ml may reduce vaccine effectiveness.
• Immunosuppressants: Avoid concurrent use with immunosuppressants, as it may lead to increased risk of infections.

Moderate Interactions (Monitor Closely)

• Nephrotoxic drugs: Monitor kidney function closely when used with nephrotoxic medications.
• Anticoagulants: Monitor for signs of blood clots or bleeding when used with anticoagulants.
• Diuretics: Monitor fluid balance and kidney function when used with diuretics.